These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1224 related items for PubMed ID: 16532321

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis.
    Shaarawy M, Zaki S, Sheiba M, El-Minawi AM.
    Clin Lab; 2003 Mar; 49(11-12):625-36. PubMed ID: 14651333
    [Abstract] [Full Text] [Related]

  • 6. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK, Pietropolli A, Ticconi C, Gravotta E, De Martino MU, Fabbri A, Piccione E.
    J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
    [Abstract] [Full Text] [Related]

  • 7. Biochemical markers as predictors of rates of bone loss after menopause.
    Rogers A, Hannon RA, Eastell R.
    J Bone Miner Res; 2000 Jul; 15(7):1398-404. PubMed ID: 10893690
    [Abstract] [Full Text] [Related]

  • 8. Cathepsin K predicts femoral neck bone mineral density change in nonosteoporotic peri- and early postmenopausal women.
    Prezelj J, Ostanek B, Logar DB, Marc J, Hawa G, Kocjan T.
    Menopause; 2008 Jul; 15(2):369-73. PubMed ID: 17882010
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D.
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [Abstract] [Full Text] [Related]

  • 13. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.
    Chen P, Satterwhite JH, Licata AA, Lewiecki EM, Sipos AA, Misurski DM, Wagman RB.
    J Bone Miner Res; 2005 Jun; 20(6):962-70. PubMed ID: 15883636
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements.
    Akin O, Göl K, Aktürk M, Erkaya S.
    Gynecol Endocrinol; 2003 Feb; 17(1):19-29. PubMed ID: 12724015
    [Abstract] [Full Text] [Related]

  • 15. [Relationships between circulating matrix metalloproteinase-1, -2 and metalloproteinase-1 levels and bone biochemical markers and bone mineral density in Chinese postmenopausal women].
    Guo LJ, Luo XH, Wu XP, Xie H, Zhou HD, Zhang H, Cao XZ, Liao EY.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 23; 85(11):734-7. PubMed ID: 15949377
    [Abstract] [Full Text] [Related]

  • 16. Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal osteoporosis.
    Shaarawy M, Abassi AF, Hassan H, Salem ME.
    Fertil Steril; 2003 Apr 23; 79(4):919-24. PubMed ID: 12749431
    [Abstract] [Full Text] [Related]

  • 17. Dissociation between global markers of bone formation and direct measurement of spinal bone formation in osteoporosis.
    Frost ML, Fogelman I, Blake GM, Marsden PK, Cook G.
    J Bone Miner Res; 2004 Nov 23; 19(11):1797-804. PubMed ID: 15476579
    [Abstract] [Full Text] [Related]

  • 18. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL, Loft AG, Møller N, Weeke J, Eriksen EF, Mosekilde L, Charles P.
    J Bone Miner Res; 1997 Jan 23; 12(1):78-88. PubMed ID: 9240729
    [Abstract] [Full Text] [Related]

  • 19. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
    Burshell AL, Möricke R, Correa-Rotter R, Chen P, Warner MR, Dalsky GP, Taylor KA, Krege JH.
    Bone; 2010 Apr 23; 46(4):935-9. PubMed ID: 20060081
    [Abstract] [Full Text] [Related]

  • 20. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
    Vlasiadis KZ, Damilakis J, Velegrakis GA, Skouteris CA, Fragouli I, Goumenou A, Matalliotakis J, Koumantakis EE.
    Maturitas; 2008 Mar 20; 59(3):226-33. PubMed ID: 18342460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.